Products
MupiroNasal 20 mg/g nasal ointment
| Generic name: | Mupirocin |
| АТС code: | R01AX06 |
| Composition: | 1 g nasal ointment contains: Mupirocin 20 mg |
| Group: | Respiratory System |
MupiroNasal 20 mg/g nasal ointment nasal, manufactured by Balkanpharma-Razgrad AD, is a medicinal product containing the active substance mupirocin, as mupirocin calcium, intended for use in the nose.
Mupirocin is an antibacterial agent for topical use and a medicinal agent of choice for elimination of Staphylococci, incl. methicillin-resistant strains of S. aureus (MRSA) in the nose.
Mupirocin is active against most microorganisms, causing skin bacterial infections - furuncles, impetigo, open wounds and others.
Mupirocin is suitable for preoperative elimination of nasal carriage of S. aureus in patients in intensive care units, patients undergoing cardio-thoracic surgical intervention, patients of abdominal surgery, patients undergoing orthopaedic surgical intervention, e.g. joint arthroplasty, patients of neurosurgery, patients of eye surgery, patients undergoing haemodialysis and peritoneal dialysis, for reducing S. aureus colonisation in HIV-positive patients.
As a result of its specific mode of action and unique chemical structure, mupirocin shows no cross-resistance with other antibiotics, and the risk for development of resistant bacteria is low, when using the product in accordance with its therapeutic indications.
Subgroup:
Decongestants and other nasal preparations for topical use
Medical product subject to medical prescription
Route (s) of administration: Nasal use
Nature and contents of container: MupiroNasal 20 mg/g ointment of 3 g in an aluminium tube fitted with a cannula and closed with a screw cap.
One tube with a patient leaflet is inserted in a cardboard carton.
Prescriptions:
MupiroNasal is a local antibiotic that is used to treat bacterial infections of the nose. It is also used to remove nasal carriage of certain types of bacteria (the so-called Staphylococci), which commonly cause infections in haemodialysis patients.
Products manufactured under contract
| Generic name | Pharmaceutical form | АТС code |
|---|---|---|
| Acetylsalicylic acid | Tablets 500 mg | C01DA05 |
| Azithromycin | Powder for oral suspension 200 mg/5 ml, 20 ml | J01FA10 |
| Azithromycin | Hard capsules 250 mg | J01FA10 |
| Azithromycin | Powder for oral suspension 100 mg/5 ml, 20 ml | J01FA10 |
| Bifonazole | Cream 1%, 15 g | D01AC10 |
| Chloramphenicol | Hard capsules 250 mg | J01BA01 |
| Chloramphenicol | Ointment 2 %, 20 g | D06AX02 |
| Cinnarizine | Tablets 25 mg | N07CA02 |
| Clindamycin | Hard capsules 150 mg | J01FF01 |
| Clobetasol propionate | Cream 0,5 mg/g, 15 g | D07AD01 |
| Clobetasol propionate | Ointment 0,5 mg/g, 15 g | D07AD01 |
| Dequalinium chloride; Ascorbic acid | Compressed lozenges | C01DA05 |
| Dexamethasone, Tobramycin | Eye drops, suspension 3 mg/ml + 1 mg/ml, 5 ml | S01CA01 |
| Dimenhydrinate | Tablets 50 mg | R06AA00 |
| Doxycyclin | Hard capsules 100 mg | J01AA02 |
| Fluconazole | Hard capsules 100 mg | J02AC01 |
| Fluconazole | Hard capsules 50 mg | J02AC01 |
| Fluocinolone acetonide | Cream 0,25 mg/g, 15 g | D07AC04 |
| Fluocinolone acetonide | Ointment 0,25 mg/g, 15 g | D07AC04 |
| Fluocinolone acetonide, Neomycin | Cream 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
| Fluocinolone acetonide, Neomycin | Ointment 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
| Gentamicin | Cream 1 mg/g, 15 g | D06AX07 |
| Gentamicin | Ointment 1 mg/g, 15 g | D06AX07 |
| Gentamicin, Hydrocortisone | Cream 1 mg/g + 10 mg/g, 15 g | D07CA01 |
| Gentamicin, Hydrocortisone | Ointment 1 mg/g + 10 mg/g, 15 g | D07CA01 |
| Hydrochlorothiazide | Tablets 25 mg | C03AA03 |
| Hydrocortisone, Chloramphenicol | Eye drops, suspension 10 mg/ml + 2 mg/ml, 5 ml | S01CA03 |
| Hydrocortisone, Neomycin | Cream 10 mg/g + 3,5 mg/g, 15 g | D07CA01 |
| Hydrocortisone, Neomycin | Ointment 25 mg/g + 25 mg/g, 10 g | D07CA01 |
| Indapamide hemihydrate | Film-coated tablets 2,5 mg | C03BA11 |
| Isosorbide dinitrate | Tablets 10 mg | C01DA08 |
| Isosorbide dinitrate | Prolonged-realese tablets 20 mg | C01DA08 |
| Lincomycin | Hard capsules 500 mg | J01FF02 |
| Lovastatin | Tablets 20 mg | C10AA02 |
| Lovastatin | Tablets 40 mg | C10AA02 |
| Magnesium DL-aspartate tetrahydrate, Potassium DL-aspartate hemihydrate | Film-coated tablets 175 mg + 166 mg | A12BA30 |
| Metamizole sodium, Thiamine hydrochloride, Caffeine | Tablets 500 mg + 50 mg + 38,75 mg | N02BB52 |
| Nystatin | Tablets 500 000 IU | A07AA02 |
| Nystatin | Cream 100 000 IU/g, 15 g | D01AA01 |
| Nystatin | Ointment 100 000 IU/g, 15 g | D01AA01 |
| Oleandomycin, Dexamethasone, Indometacin | Oromucisal paste 50 mg/g + 10 mg/g + 50 mg/g, 5 ml | A01AD11 |
| Papaverine hydrochloride | Tablets 50 mg | A03AD01 |
| Pentaerithrityl tetranitrate | Tablets 10 mg | C01DA05 |
| Piracetam | Hard Capsules 400 mg | N06BX03 |
| Piracetam | Film-coated tablets 800 mg | N06BX03 |
| Propranolol hydrochloride | Tablets 20 mg | C07AA05 |
| Propranolol hydrochloride | Tablets 40 mg | C07AA05 |
| Rifampicin | Hard capsules 300 mg | J04AB02 |
| Tetracycline | Hard capsules 250 mg | J01AA07 |
| Tetracycline | Ointment 3 %, 20 g | D06AA04 |
| Tobramycin | Eye drops, solution 0,3 %, 5 ml | S01AA12 |
| Triamterene, Hydrochlorothiazide | Tablets 25 mg + 12,5 mg | C03EA01 |
| Troxerutin | Hard capsules 300 mg | C05CA04 |
New products
Aciclovir Vision 30 mg/g eye ointment
Subgroup: Antiinfectives, Antiviral products Medical product subject to medical prescription Route (s) of administration: Ocular use Nature and contents of container: The medicinal product is packe...
More
Prednisolon F 2 mg tablets
Subgroup: Glucocorticoids Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: 10 (ten) tablets are packed in a PVC / PVdC / AL fo...
More
Inosipranol 500 mg and 1000 mg powder for oral solution
Subgroup: Direct acting antivirals, Other antivirals Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: Inosipranol 500 m...
More
Clindavasin D 10 mg/ml cutaneous solution
Indications: Clindavasin D 10 mg/ml cutaneous solution is used to apply to the skin to treat acne vulgaris. Medical product subject to medical prescription Route (s) of administration: Clindavasin D...
More